Fjalar Kristjansson

Fjalar Kristjansson

Active Director Director DIN 02504768
DIN 02504768 First appointment Mar 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Mar 2005
Shareholding value •••• Premium profile

About Fjalar Kristjansson

Data last updated:

Fjalar Kristjansson is a Director at Alvogen Pharma (India) Private Limited (since 2010) and Director at Norwich Clinical Services Private Limited (since 2010). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Alvogen Pharma (India) Private Limited at ₹51.32 Cr (FY 2025). Earlier, Fjalar Kristjansson was a Director at Lotus Labs Private Limited (2005–2010) and Director at Lotus Clinical Research Academy Private Limited (from 2007).

DIN 02504768
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2005
Oldest Company Age 20 yrs
Largest company Alvogen Pharma (India) Private Limited · ₹51.32 Cr (FY 2025)
Combined revenue ₹103 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Apr 20102010₹51.32 Cr (FY 2025)Active
Director01 Feb 20102009₹51.26 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lotus Labs Private Limited U73100MH1999PTC272443
Director18 Mar 20051999₹54.98 Cr (FY 2025)Active
Director15 Jan 20072006Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lotus Clinical Research Academy Private Limited
Norwich Clinical Services Private Limited
Alvogen Pharma (India) Private Limited
Lotus Labs Private Limited
Premium access

Shareholding and investment profile for Fjalar Kristjansson

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fjalar Kristjansson

Fjalar Kristjansson currently holds 2 directorships: Alvogen Pharma (India) Private Limited (Director, since 13 Apr 2010, revenue ₹51.32 Cr (FY 2025)); Norwich Clinical Services Private Limited (Director, since 01 Feb 2010, revenue ₹51.26 Cr (FY 2025)).

Fjalar Kristjansson was first appointed on 18 Mar 2005 as Director at Lotus Labs Private Limited. The most recent appointment on record is 13 Apr 2010 at Alvogen Pharma (India) Private Limited.

The 2 current companies of Fjalar Kristjansson that report revenue have a combined latest revenue of ₹103 Cr: Alvogen Pharma (India) Private Limited ₹51.32 Cr (FY 2025); Norwich Clinical Services Private Limited ₹51.26 Cr (FY 2025).

Fjalar Kristjansson held 2 earlier board appointments: Lotus Labs Private Limited (Director, 18 Mar 2005 to 02 Feb 2010); Lotus Clinical Research Academy Private Limited (Director, from 15 Jan 2007).

The current boards of Fjalar Kristjansson's companies include Aditya Nagaraj Bellur (Alvogen Pharma (India) Private Limited), Divya Chandu Patel (Alvogen Pharma (India) Private Limited), Saral Thangam (Alvogen Pharma (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available